Apotex claims "import alert" broke NAFTA rules; seeks over $500M from US
This article was originally published in Scrip
Executive Summary
Canadian generic drug giant Apotex alleges a US "import alert" imposed by the FDA that blocked US shipments from two of its Canadian plants in 2009 "decimated" its business by treating it more harshly than its competitors, in violation of the North American Free Trade Agreement (NAFTA).